Abstract
Polymerase Chain reaction (PCR) is a key tool to diagnose Covid-19. Yet access to PCR is often limited. In this paper, we develop a clinical strategy for prescribing PCR to patients based on data from COVIDOM, a French cohort of 54,000 patients with clinically suspected Covid-19 including 12,810 patients tested by PCR. Using a machine learning algorithm (a decision tree), we show that symptoms alone are sufficient to predict PCR outcome with a mean average precision of 86%. We identify combinations of symptoms that are predictive of PCR positivity (90% for anosmia/ageusia) or negativity (only 30% of PCR+ for a subgroup with cardiopulmonary symptoms): in both cases, PCR provides little added diagnostic value. We deduce a prescribing strategy based on clinical presentation that can improve the global efficiency of PCR testing.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not a clinical trial
Funding Statement
The authors declare no specific funding for this study. COVIDOM received funding by the Programme Hospitalier de Recherche Clinique 2020 of the French Ministry of Health, by a research fund by APHP-Fondation de France and from the EIT Health specific Covid-19 fund. Arthur Mensch was funded by ERC grant Noria.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by the Scientific and ethical committee of APHP (IRB00011591), Paris, France
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Scientific committee: AIME-EUSEBI Amélie, APRA Caroline, BLEIBTREU Alexandre, DEBUC Erwan, DECHARTRES Agnès, DECONINCK Laurène, DINH Aurélien, JOURDAIN Patrick, KATLAMA Christine, LEBEL Josselin, LESCURE François-Xavier, YORDANOV Youri
Covidom regional center steering committee: ARTIGOU Yves, BANZET Amélie, BOUCHERON Elodie, BOUDIER Christiane, BUZENAC Edouard, CHAPRON Marie-Claire, CHEKAOUI Dalhia, DE BASTARD Laurent, DEBUC Erwan, DINH Aurélien, GRENIER Alexandre, HAAS Pierre-Etienne, HODY Julien, JARRAYA Michèle, JOURDAIN Patrick, LACAILLE Louis, LE GUERN Aurélie, LECLERT Jeremy, MALE Fanny, MARCHAND-ARVIER Jerôme, MARTIN-BLONDET Emmanuel, NASSOUR Apolinne, OURAHOU Oussama, PENN Thomas, RIBARDIERE Ambre, ROBIN Nicolas, ROUGE Camille, SCHMIDT Nicolas, VILLIE Pascaline
Data Availability
Data and code available on request for academic researchers
